Search by Drug Name or NDC
NDC 71287-0219-02 TECARTUS 2000000 1/68mL Details
TECARTUS 2000000 1/68mL
TECARTUS is a INTRAVENOUS SUSPENSION in the CELLULAR THERAPY category. It is labeled and distributed by Kite Pharma, Inc.. The primary component is BREXUCABTAGENE AUTOLEUCEL.
MedlinePlus Drug Summary
Brexucabtagene autoleucel is used to treat mantle cell lymphoma (a fast-growing cancer that begins in the cells of the immune system) in adults that has returned or is unresponsive to other treatment(s). Brexucabtagene autoleucel is also used to treat certain acute lymphoblastic leukemia (ALL; also called acute lymphoblastic leukemia and acute lymphatic leukemia; a type of cancer that begins in the white blood cells) in adults that has returned or is unresponsive to other treatment(s). Brexucabtagene autoleucel injection is in a class of medications called autologous cellular immunotherapy, a type of medication prepared using cells from the patient's own blood. It works by causing the body's immune system (a group of cells, tissues, and organs that protects the body from attack by bacteria, viruses, cancer cells, and other substances that cause disease) to fight the cancer cells.
Related Packages: 71287-0219-02Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Brexucabtagene Autoleucel Injection
Product Information
| NDC | 71287-0219 |
|---|---|
| Product ID | 71287-219_2d3bc6ab-ff21-46f0-a4c7-1fcc1e4b9e22 |
| Associated GPIs | 21651020101820 |
| GCN Sequence Number | 081329 |
| GCN Sequence Number Description | brexucabtagene autoleucel PLAST. BAG 2X10EXP8 INTRAVEN |
| HIC3 | V35 |
| HIC3 Description | ANTINEOPLASTIC - CAR-T CELL IMMUNOTHERAPY |
| GCN | 48404 |
| HICL Sequence Number | 046733 |
| HICL Sequence Number Description | BREXUCABTAGENE AUTOLEUCEL |
| Brand/Generic | Brand |
| Proprietary Name | TECARTUS |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | brexucabtagene autoleucel |
| Product Type | CELLULAR THERAPY |
| Dosage Form | SUSPENSION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 2000000 |
| Active Ingredient Units | 1/68mL |
| Substance Name | BREXUCABTAGENE AUTOLEUCEL |
| Labeler Name | Kite Pharma, Inc. |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | BLA |
| Application Number | BLA125703 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 71287-0219-02 (71287021902)
| NDC Package Code | 71287-219-02 |
|---|---|
| Billing NDC | 71287021902 |
| Package | 1 BAG in 1 PACKAGE (71287-219-02) / 68 mL in 1 BAG (71287-219-01) |
| Marketing Start Date | 2020-07-24 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |